CYCS and cancer: To create chemoresistance in cancer treatment, targeting mitochondria to destroy cancer cells might be preferable over ligand-receptor interactions, as the release of cytochrome c (cyt c) from the mitochondria is only a prominent event within the intrinsic induction and apoptosis signaling cascade [14].